Back to search

Article

Engineering Synthetic and Recombinant Human Lysosomal b-Glucocerebrosidase for Enzyme Replacement Therapy for Gaucher Disease

2024-07-19

Abstract excerpt

<title>Abstract</title> <p>Gaucher Disease (GD) is an autosomal recessive, lysosomal storage disease caused by pathogenic variants in the glucocerebrosidase gene, leading to the loss of b-glucocerebrosidase (GCase) enzymatic activity. Enzyme replacement therapy (ERT) with recombinant GCase is the standard of care in GD patients. Our study investigates the combined use of <italic>in silico</italic> molecular evolu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2bb63f66-1ddd-5d61-9c55-16bafcb39e1a
DOI
10.21203/rs.3.rs-4625596/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Engineering Synthetic and Recombinant Human Lysosomal b-Glucocerebrosidase for Enzyme Replacement Therapy for Gaucher DiseaseDOI 10.21203/rs.3.rs-4625596/v1
Select a neighboring publication to make it the new centre.